There has been a breakthrough in the treatment of the previously untreatable form of macular degeneration (‘dry AMD‘).
Kentucky vision Scientists have discovered the complex chain reaction of proteins and enzymes that happens in the retina causing dry AMD. They demonstrated that using drugs to selectively block these proteins and enzymes halted the process in various disease models.
There has been no trial on humans yet but this gives hope to millions suffering from dry AMD. Usually taken to be the unstoppable ageing process of the retina, dry AMD can get progressively worse with no effective treatment options. This new breakthrough could open up a whole raft of drug therapies to halt or prevent the condition developing.
